Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The America Watch.
Press releases published on April 25, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NYSE: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@ …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE: ECG). Such investors are advised to contact Danielle Peyton at …
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bakkt Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - BKKT
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT). Such investors are advised to contact Danielle Peyton at newaction@ …
DEADLINE ALERT for SEI, SOUN, and BKKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
·
April 25, 2025
LOS ANGELES, April 25, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed …
John W. Kennedy to Share Insightful Reflections at LA Times Festival of Books
EIN Presswire
·
April 25, 2025
Engineer-turned-author challenges the culture of blame and highlights the power of real dialogue. COOKSTOWN, NJ, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- The Reading Glass Books is excited to host author and mechanical engineer John W. …
Fundraising Effectiveness Project Data for Q4 2024 highlights the growing role of high-dollar donors in driving fundraising performance across the sector
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Q4 2024 fundraising data from the Fundraising Effectiveness Project (FEP) released today shows an increase of 3.5% in dollars raised compared to 2023 levels. However, despite the increase in total dollars, it is …
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)
GlobeNewswire
·
April 25, 2025
UK Medicines and Healthcare products Regulatory Agency (MHRA) authorisation based on FELIX clinical trial of obecabtagene autoleucel in adult patients with r/r B-ALL1 AUCATZYL® licensed from MHRA under ‘conditional marketing authorisation’, meaning that …
Mic Lowther Delivers Mystery, Adventure, and a High-Stakes Chase for Hidden Fortune in Seventeen Parcels
EIN Presswire
·
April 25, 2025
A Gripping Treasure Hunt Across America LOS ANGELES, CA, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- "Seventeen Parcels" takes readers on an exhilarating journey filled with intrigue, secrets, and an unconventional treasure hunt. Mic Lowther’s …
Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC
GlobeNewswire
·
April 25, 2025
OOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD3 at the National Bone Health …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation – FLYW
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE: ATNM). Such investors are advised to contact Danielle Peyton at …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. – PLRX
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (“Pliant” or the “Company”) (NASDAQ: PLRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …
Fermbox Bio Secures Multi-million Dollar Cellulosic Enzymes Supply Contract with An Indian 2G Ethanol Company
EIN Presswire
·
April 25, 2025
Marks first large-scale commercialization of Fermbox Bio’s EN3ZYME, supporting India’s 2G ethanol push with flexible supply models BENGALURU, KARNATAKA, INDIA, April 25, 2025 /EINPresswire.com/ -- Fermbox Bio, a biotechnology research and manufacturing …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultra Clean Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - UCTT
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ultra Clean Holdings, Inc. (“Ultra Clean” or the “Company”) (NASDAQ: UCTT). Such investors are advised to contact Danielle Peyton at …
Ov Finance Upgrades Blockchain Infrastructure to Deliver Faster, Safer Digital Asset Trading
GlobeNewswire
·
April 25, 2025
Atlanta, GA, April 25, 2025 (GLOBE NEWSWIRE) -- Ov Finance, a financial technology and cryptocurrency company, has announced a major upgrade to its blockchain infrastructure aimed at boosting platform performance, enhancing security, and enabling seamless …
Chameleon Finance Launches Green Finance Initiative to Advance Sustainable Digital Asset Infrastructure
GlobeNewswire
·
April 25, 2025
SEATTLE, WA, April 25, 2025 (GLOBE NEWSWIRE) -- Chameleon Finance, a global financial technology company, has announced the launch of a green finance initiative focused on embedding environmental sustainability into blockchain-based financial systems. This …
Hubbell Incorporated Declares Regular Quarterly Dividend
GlobeNewswire
·
April 25, 2025
Shelton, CT, April 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.32 per share on the Company’s common stock. The dividend will be paid June 16, 2025 to shareholders …